With reference to the captioned subject, the company hereby inform that the Board of Directors of the Company in the meeting held on Wednesday, August 13, 2025 has discussed, took noted ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Desh Rakshak Aushdhalaya Limited, a Haridwar-based Ayurvedic medicines maker, met on August 13, 2025 and approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Total revenue stood at ₹129.99 lakhs, up from ₹108.24 lakhs in the same quarter last year, a growth of about 20%. Net profit came in at ₹9.59 lakhs versus ₹9.33 lakhs earlier, with basic EPS of ₹0.22. The statutory auditor Anil Jain & Co. issued a limited review report with an unmodified opinion. The board also appointed Mrs. Cheena Golani and Mr. Rajesh Kumar Gupta as Additional Independent Directors for a five-year term, subject to shareholder approval.
A roughly 20% year-on-year revenue rise is a positive growth signal for this small-cap Ayurvedic company, though profit growth was modest at under 3%. The clean (unmodified) auditor opinion and addition of two independent directors support governance, with no material red flags in this filing.